
Raffaele Ingenito, PhD
CEO of Enhydro Science since January 2026 and co-founder of the company in 2023. Scientific and strategic leader with more than 25 years of experience across pharmaceutical research and development, project coordination and clinical operations.
His expertise includes peptide- and protein-based therapeutics, translational research, R&D strategy, intellectual property and collaboration with scientific and clinical partners.
